Article
From Gene to Hope: Rett Syndrome and the Rise of Molecular Therapies.
Molecular diagnosis & therapy - 1 Jul 2026
Leblay Yoann, Felix Marie-Solenne, Roux Jean-Christophe, Panayotis Nicolas
Abstract excerpt
Rett syndrome is a rare X-linked neurodevelopmental disorder caused by mutations in MECP2, a gene critical for neuronal function, chromatin organization, and synaptic plasticity. After a period of apparently normal early development, individuals with Rett syndrome experience rapid regression followed by lifelong neurological impairment. Notably, preclinical studies have shown that restoration of MeCP2 expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
